GC Biopharma Corp (006280) Stock Price & News

006280:KRX

GC Biopharma Corp

₩122,700.00

+0.25%

(+300.00) 1D

Sep 17, 3:30:10 PM GMT+9 · KRW

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for 006280...

Open

₩123,600

High

₩124,200

Low

₩122,000

Mkt. cap

1.43T

Avg. vol.

23.84K

Volume

12.74K

Dividend

1.22%

Quarterly dividend

₩375

Ex-dividend date

Mar 30, 2026

52-wk high

₩183,800

52-wk low

₩105,900

EPS

-₩4,372

Shares outstanding

11.69M

No. of employees

Open

₩123,600

High

₩124,200

Low

₩122,000

Mkt. cap

1.43T

Avg. vol.

23.84K

Volume

12.74K

Dividend

1.22%

Quarterly dividend

₩375

Ex-dividend date

Mar 30, 2026

52-wk high

₩183,800

52-wk low

₩105,900

EPS

-₩4,372

Shares outstanding

11.69M

No. of employees

Related stocks

Hanall Biopharma Co Ltd

₩48,150.00

+0.84%

Profile

GC Biopharma also known as Green Cross Corporation is a biopharmaceutical company headquartered in Yongin, South Korea. Wikipedia

About GC Biopharma Corp

CEOEun Chul Huh | Il-sup Huh

Employees2.11K

FoundedOct 5, 1967

Headquarters-

SectorBiotechnology

Websitegcbiopharma.com

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	609.49B	497.75B	435.53B	421.18B
Cost of goods sold	463.97B	357.85B	313.13B	312.00B
Cost of revenue	463.97B	357.85B	313.13B	312.00B
Research and development expenses	33.48B	44.81B	35.32B	38.34B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	77.09B	83.01B	70.35B	65.07B
Operating expense	116.30B	135.30B	110.67B	107.45B
Total operating expenses	580.27B	493.15B	423.80B	419.45B
Operating income	29.21B	4.60B	11.73B	1.73B
Other non operating income	13.04M	636.32M	-10.15B	-6.20B
EBT including unusual items	24.89B	-110.07B	28.59B	-1.60B
EBT excluding unusual items	21.52B	-4.39B	25.91B	-14.17B
Income tax expense	6.74B	-7.27B	8.45B	-2.65B
Effective tax rate	27.07%	6.61%	29.56%	165.54%
Other operating expenses	296.00M	306.00M	590.00M	308.00M
Net income	15.95B	-88.30B	20.47B	1.98B
Net profit margin	2.62%	-17.74%	4.70%	0.47%
Earnings per share	1.40K	-	1.79K	174.00
Interest and investment income	605.00M	623.00M	881.00M	418.00M
Interest expense	-12.76B	-13.40B	-13.27B	-11.50B
Net interest expenses	-12.15B	-12.77B	-12.39B	-11.08B
Depreciation and amortization charges	1.68B	2.17B	1.63B	1.22B
EBITDA	50.70B	24.79B	34.46B	22.90B
Gain or loss from assets sale	-268.00M	1.01B	-35.56B	38.60M

Finance

Ask anything